http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112716948-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_757f25f5194060245a72e4b0465e8993 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-718 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-718 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 |
| filingDate | 2021-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef3d10918d4fc1967bd0b9e27375a1e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11d6a4109d5a80148107cbb3dce1f579 |
| publicationDate | 2021-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112716948-A |
| titleOfInvention | Application of dihydroberberine in preparing medicine for treating ulcerative colitis |
| abstract | The invention belongs to the field of medicines, and discloses an application of dihydroberberine in preparation of a medicine for treating ulcerative colitis, wherein the structural formula of the dihydroberberine is shown as a formula (I). The invention indicates that the dihydroberberine can obviously improve the general symptoms of the ulcerative colitis mouse, improve the pathological changes, reduce the activity of myeloperoxidase, inhibit the content of proinflammatory cytokines and increase the expression of colon tight junction protein, thereby improving the intestinal mucosa barrier function and having obvious effect of treating the ulcerative colitis. |
| priorityDate | 2021-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 194.